How to Buy Irhythm Technologies Stock
Irhythm Technologies Inc
iRhythm Technologies, Inc. , a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.
Irhythm Technologies stock last closed at $143.85, down 1.12% from the previous day, and has increased 55.01% in one year. It has overperformed other stocks in the Medical Devices industry by 0.72 percentage points. Irhythm Technologies stock is currently +157.24% from its 52-week low of $55.92, and -4.1% from its 52-week high of $150.00.
There are currently 31.93M IRTC shares outstanding. The market capitalization of IRTC is $4.59B. In the past 24 hours, 316,000 IRTC shares were traded.
How to Buy Irhythm Technologies Stock
Not sure how to invest in Irhythm Technologies stock? Here's how.
- Choose where to buy Irhythm Technologies stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Irhythm Technologies stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your method of payment and add your info.
- Evaluate Irhythm Technologies stock: The Irhythm Technologies ticker symbol is IRTC. Is Irhythm Technologies stock a good investment? Should you buy shares of IRTC? How do IRTC's underlying business fundamentals look? Do top analysts think Irhythm Technologies is a good buy? Why has IRTC's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if IRTC is a good stock to buy).
- Execute your IRTC buy order: Decide if you will purchase IRTC shares at the current market price or use a limit order to buy IRTC stock at a particular price.
- Keep tabs on your investment in IRTC: Create a watchlist to important updates regarding your position in Irhythm Technologies stock.
Step 1: Choose where to buy Irhythm Technologies stock
You will need a brokerage account to access the NASDAQ market and buy IRTC shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, you need to fill out some personal details so you can invest in IRTC today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on our top ranked stock app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring funds into your new brokerage account.
Step 4: Evaluate Irhythm Technologies stock
Once you have selected the best place to buy Irhythm Technologies stock, it's very important to analyze their stock prior to buying, so you truly wrap your head around the risk and opportunity.
Irhythm Technologies Metrics
Irhythm Technologies Overview
WallStreetZen was created to help average investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on IRTC's stock page.
What is the fair value of IRTC stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge IRTC's intrinsic value.
Using relative valuations methods:
- IRTC may be overvalued based on its P/B ratio of 52.99x, relative to Medical Devices industry P/B ratio of 3.99x
You can access additional valuation analysis on IRTC's stock here.
IRTC Financial Health Overview
Signs that IRTC is financially healthy:
- IRTC profit margin has gone up from -25.3% to -15.9% in the past year.
- There are more short-term assets than short-term liabilities on the IRTC balance sheet.
Signs that IRTC is not financially healthy:
- IRTC's operating cash flow of $47.53M allows it to safely service it's debt of $735.50M.
- IRTC earnings of -$83.89M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the IRTC balance sheet.
- IRTC has a relatively high debt to equity ratio of 9.69.
- Total IRTC debt is higher than 5 years ago, relative to shareholder equity.
Is Irhythm Technologies stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 9 Wall Street analysts who give forecasts on IRTC, the consensus analyst rating on IRTC is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent IRTC Analyst Ratings
David Saxon, a bottom 10% analyst from Needham maintains IRTC with a buy rating and raises their IRTC price target from $138.00 to $151.00, on May 2, 2025.
David Roman, a bottom 10% analyst from Goldman Sachs maintains IRTC with a hold rating and raises their IRTC price target from $91.00 to $124.00, on Feb 24, 2025.
Richard Newitter, a top 6% analyst from Truist Securities maintains IRTC with a strong buy rating and raises their IRTC price target from $111.00 to $145.00, on Feb 21, 2025.
Truist Securities's Richard Newitter raised their price target on Irhythm Technologies (NASDAQ: IRTC) by 30.6% from $111 to $145 on 2025/02/21. The analyst maintained their Strong Buy rating on the stock.
iRhythm Technologies reported its Q4 and FY 2024 earnings.
Newitter noted that the quarter's EBITDA and EPS beats "complemented" its pre-announced revenue beat.
Management reiterated its FY 2025 revenue growth guidance of 16% to 18%, the analyst added commenting that iRhythm Technologies "tends to guide conservatively, and we see built-in upside."
Earnings Report
iRhythm Technologies reported:
For Q4 2024:
- EPS of $0.01, which beat the Zacks Consensus Estimate of $(0.30) and Q4 2023's $(0.84).
- Revenue of $164.33M, which beat the Zacks Consensus Estimate by 4.19% and Q4 2023's $132.51M.
For FY 2024:
- Loss per share of $3.08, up from FY 2023's $(3.16).
- Revenue of $591.8 M, up 20.1% Y/Y.
For FY 2025, management guided:
- Revenue of $675M to $685M.
President & CEO Quentin Blackford commented: "Our fourth quarter capped a transformative year for iRhythm, marked by 24% revenue growth and significant operational achievements.
"We achieved record new account onboarding, with balanced volume contributions across multiple channels, particularly in risk-bearing, primary care settings where Zio's value as a population health management tool has resonated strongly.
"Throughout 2024, we enhanced our quality systems, improved customer experience through EHR integration and innovative product launches, expanded into multiple international markets, and secured strategic technology licensing agreements to advance connected patient care.
"Our commitment to operational discipline has yielded positive cash flow for three consecutive quarters, while our extensive scientific publications have further validated our approach.
"Looking ahead, we remain focused on delivering a best-in-class quality system while creating shareholder value through our strategies of expanding our core U.S. market presence, accelerating international growth, advancing product innovation, and further advancing operational efficiencies.
"As we scale the Zio platform globally, we're uniquely positioned to shape the future of healthcare while driving value for patients, physicians, health systems, and shareholders."
Suraj Kalia, a bottom 16% analyst from Oppenheimer maintains IRTC with a buy rating and raises their IRTC price target from $105.00 to $120.00, on Jan 8, 2025.
You can dig deeper into what analysts are projecting on the Irhythm Technologies stock forecast page.
IRTC Technicals
IRTC Performance Numbers
Last year, IRTC revenue was $618.59M. During the last 5 year, IRTC's revenue has grown by 21.91% per year. This was faster than the Medical Devices industry average of 9.62%.
Dive into IRTC's earnings and revenue performance here.
Latest Insiders Trades at IRTC
In the past year, insiders at IRTC have sold more shares than they have bought.
Chad Patterson, Chief Commercial Officer of IRTC, was the latest IRTC insider to sell. They sold $54,450.00 worth of IRTC shares on Jun 10, 2025.
Dig into more about who owns IRTC shares here.
Does IRTC stock generate passive income?
No, Irhythm Technologies doesn't provide an income stream by paying out dividends.
IRTC Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your IRTC buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open button and eToro will place the order.
If you require more info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your investment in IRTC
Now that you own some shares in IRTC, you'll want to stay up-to-date on your shares.
Create a watchlist to get notified of the latest news about your IRTC stock.
IRTC Feed
How to Buy Stock in Irhythm Technologies
To reiterate, here are the 6 steps for buying Irhythm Technologies stock:
- Choose where to buy Irhythm Technologies stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Irhythm Technologies stock
- Execute your IRTC buy order
- Keep tabs on your investment in IRTC
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Irhythm Technologies, create a watchlist today.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.